{"id":"NCT01108731","sponsor":"Beth Israel Medical Center","briefTitle":"The Effect of Milnacipran in Patients With Fibromyalgia","officialTitle":"The Effect of Milnacipran or Placebo on Ventricular Lactate Levels and Fibromyalgia Induced \"Brain Fog.\"","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2010-03","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2010-04-22","resultsPosted":"2014-10-15","lastUpdate":"2016-06-30"},"enrollment":37,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Fibromyalgia"],"interventions":[{"type":"DRUG","name":"Milnacipran","otherNames":["Savella"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Patients taking the drug Milnacipran","type":"ACTIVE_COMPARATOR"},{"label":"Patients taking the placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Use of the drug Milnacipran will reduce ventricular lactate levels and processing time for completing complex tasks relative to placebo.","primaryOutcome":{"measure":"Change in Ventricular Lactate Levels in the Brain","timeFrame":"Baseline and 2 months","effectByArm":[{"arm":"Patients Taking the Drug Minalcipran","deltaMin":-0.87,"sd":0.91},{"arm":"Patients Taking the Placebo","deltaMin":0.32,"sd":1.58}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26335989"],"seeAlso":["http://www.painandfatigue.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":17},"commonTop":["Gastric distress, nausea or vomiting"]}}